Baohua Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Baohua Zhang has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
Pinghua Yang
Department of Biliary Surgery IV The Eastern Hepatobiliary Surgery Hospital, Naval Medical University Shanghai China
8 shared publicationsJue Yang
Department of Biliary Tract Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, 225 Changhai Road, Shanghai, China
5 shared publicationsZhijian Wen
Department of Hepatobiliary Pancreatic Vascular Surgery The Chenggong Hospital, Xiamen University Xiamen China
4 shared publicationsHu Liu
Department of Biliary Tract Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, 225 Changhai Road, Shanghai, China
3 shared publicationsShilei Bai
Department of Hepatic Surgery II The Eastern Hepatobiliary Surgery Hospital, Naval Medical University Shanghai China
3 shared publicationsXingzhou Yan
Department of Biliary Tract Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, 225 Changhai Road, Shanghai, China
3 shared publications
Latest Publications
- Open Access
- 5 March 2024
- Published by Wiley in Cancer Reports
- Vol. 7 (3) , e1991
Nomograms to predict long‐term survival for patients with gallbladder carcinoma after resection
Background: Surgical resection remains the primary treatment option for gallbladder carcinoma (GBC). However, there is a pressing demand for prognostic tools that can refine patients' treatment choices and tailor personalized therapies accordingly.Aims: The nomograms were constructed using the data of a training cohort (n = 378) of GBC patients at Eastern Hepatobiliary Surgery Hospital (EHBH) between 2008 and 2018. The model's performance was validated in GBC patients (n = 108) at Guangzhou Centre from 2007 to 2018.Methods and results: The 5‐year overall survival (OS) rate in the training cohort was 24.4%. Multivariate analyses were performed using preoperative and postoperative data to identify independent predictors of OS. These predictors were then incorporated into preoperative and postoperative nomograms, respectively. The C‐index of the preoperative nomogram was 0.661 (95% CI, 0.627 to 0.694) for OS prediction and correctly delineated four subgroups (5‐year OS rates: 48.1%, 19.0%, 15.6%, and 8.1%, p < 0.001). The C‐index of the postoperative nomogram was 0.778 (95%CI, 0.756 –0.800). Furthermore, this nomogram was superior to the 8th TNM system in both C‐index and the net benefit on decision curve analysis. The results were externally validated.Conclusion: The two nomograms showed an optimally prognostic prediction in GBC patients after curative‐intent resection.
- 5 March 2024
- Published by Wiley in Cancer Reports
- Vol. 7 (3) , e1991
Open AccessNomograms to predict long‐term survival for patients with gallbladder carcinoma after resection
Background: Surgical resection remains the primary treatment option for gallbladder carcinoma (GBC). However, there is a pressing demand for prognostic tools that can refine patients' treatment choices and tailor personalized therapies accordingly.Aims: The nomograms were constructed using the data of a training cohort (n = 378) of GBC patients at Eastern Hepatobiliary Surgery Hospital (EHBH) between 2008 and 2018. The model's performance was validated in GBC patients (n = 108) at Guangzhou Centre from 2007 to 2018.Methods and results: The 5‐year overall survival (OS) rate in the training cohort was 24.4%. Multivariate analyses were performed using preoperative and postoperative data to identify independent predictors of OS. These predictors were then incorporated into preoperative and postoperative nomograms, respectively. The C‐index of the preoperative nomogram was 0.661 (95% CI, 0.627 to 0.694) for OS prediction and correctly delineated four subgroups (5‐year OS rates: 48.1%, 19.0%, 15.6%, and 8.1%, p < 0.001). The C‐index of the postoperative nomogram was 0.778 (95%CI, 0.756 –0.800). Furthermore, this nomogram was superior to the 8th TNM system in both C‐index and the net benefit on decision curve analysis. The results were externally validated.Conclusion: The two nomograms showed an optimally prognostic prediction in GBC patients after curative‐intent resection.
- Open Access
- 17 August 2023
- Published by Wiley
Nomograms to predict long-term survival for patients with gallbladder carcinoma after resection
Background: Surgical resection remains the primary treatment option for gallbladder carcinoma (GBC). However, there is a pressing demand for prognostic tools that can refine patients’ treatment choices and tailor personalized therapies accordingly. Methods: The nomograms were constructed using the data of a training cohort (n=378) of GBC patients at Eastern Hepatobiliary Surgery Hospital (EHBH) between 2008 and 2018. The model’s performance was validated in GBC patients (n=108) at Guangzhou Centre from 2007 to 2018. Results: The 5-year overall survival (OS) rate in the training cohort was 24.4%. Multivariate analyses were performed using preoperative and postoperative data to identify independent predictors of OS. These predictors were then incorporated into preoperative and postoperative nomograms, respectively. The C-index of the preoperative nomogram was 0.661 (95% CI, 0.627 to 0.694) for OS prediction and correctly delineated four subgroups (5-year OS rates: 48.1%, 19.0%, 15.6%, and 8.1%, p<0.001). The C-index of the postoperative nomogram was 0.778 (95%CI, 0.756–0.800). Furthermore, this nomogram was superior to the 8th TNM system in both C-index and the net benefit on decision curve analysis. The results were externally validated. Conclusions: The two nomograms showed an optimally prognostic prediction in GBC patients after curative-intent resection.
- 17 August 2023
- Published by Wiley
Open AccessNomograms to predict long-term survival for patients with gallbladder carcinoma after resection
Background: Surgical resection remains the primary treatment option for gallbladder carcinoma (GBC). However, there is a pressing demand for prognostic tools that can refine patients’ treatment choices and tailor personalized therapies accordingly. Methods: The nomograms were constructed using the data of a training cohort (n=378) of GBC patients at Eastern Hepatobiliary Surgery Hospital (EHBH) between 2008 and 2018. The model’s performance was validated in GBC patients (n=108) at Guangzhou Centre from 2007 to 2018. Results: The 5-year overall survival (OS) rate in the training cohort was 24.4%. Multivariate analyses were performed using preoperative and postoperative data to identify independent predictors of OS. These predictors were then incorporated into preoperative and postoperative nomograms, respectively. The C-index of the preoperative nomogram was 0.661 (95% CI, 0.627 to 0.694) for OS prediction and correctly delineated four subgroups (5-year OS rates: 48.1%, 19.0%, 15.6%, and 8.1%, p<0.001). The C-index of the postoperative nomogram was 0.778 (95%CI, 0.756–0.800). Furthermore, this nomogram was superior to the 8th TNM system in both C-index and the net benefit on decision curve analysis. The results were externally validated. Conclusions: The two nomograms showed an optimally prognostic prediction in GBC patients after curative-intent resection.
- 23 February 2022
- Published by Taylor & Francis in Cell Cycle
- Vol. 21 (11) , 1166-1177
miR-4461 inhibits the progression of Gallbladder carcinoma via regulating EGFR/AKT signaling
Increasing evidence has demonstrated that microRNAs (miRNAs) participated in the tumorigenesis, progression and recurrence of various malignancies including Gallbladder carcinoma (GBC). miR-4461 was reported to work as a tumor suppressor gene in renal cell carcinoma. However, the role of miR-4461 in GBC remains unknown. Herein, we show that miR-4461 is downregulated in gallbladder cancer stem cells (CSCs). Forced miR-4461 expression attenuates the self-renewal, tumorigenicity of gallbladder CSCs, and inhibits proliferation and metastasis of GBC cells. Conversely, miR-4461 knockdown promotes the self-renewal of gallbladder CSCs, and facilities proliferation and metastasis of GBC cells. Mechanistically, miR-4461 inhibits GBC progression via downregulating EGFR/AKT pathway. Special EGFR siRNA or AKT overexpression virus abolishes the discrepancy of self-renewal, tumorigenesis, growth, and metastasis between miR-4461 overexpression GBC cells and their control cells. In conclusion, miR-4461 suppresses GBC cells self-renewal, tumorigenicity, proliferation, and metastasis by inactivating EGFR/AKT signaling, and may therefore prove to be a potential therapeutic target for GBC patients.
- 23 February 2022
- Published by Taylor & Francis in Cell Cycle
- Vol. 21 (11) , 1166-1177
miR-4461 inhibits the progression of Gallbladder carcinoma via regulating EGFR/AKT signaling
Increasing evidence has demonstrated that microRNAs (miRNAs) participated in the tumorigenesis, progression and recurrence of various malignancies including Gallbladder carcinoma (GBC). miR-4461 was reported to work as a tumor suppressor gene in renal cell carcinoma. However, the role of miR-4461 in GBC remains unknown. Herein, we show that miR-4461 is downregulated in gallbladder cancer stem cells (CSCs). Forced miR-4461 expression attenuates the self-renewal, tumorigenicity of gallbladder CSCs, and inhibits proliferation and metastasis of GBC cells. Conversely, miR-4461 knockdown promotes the self-renewal of gallbladder CSCs, and facilities proliferation and metastasis of GBC cells. Mechanistically, miR-4461 inhibits GBC progression via downregulating EGFR/AKT pathway. Special EGFR siRNA or AKT overexpression virus abolishes the discrepancy of self-renewal, tumorigenesis, growth, and metastasis between miR-4461 overexpression GBC cells and their control cells. In conclusion, miR-4461 suppresses GBC cells self-renewal, tumorigenicity, proliferation, and metastasis by inactivating EGFR/AKT signaling, and may therefore prove to be a potential therapeutic target for GBC patients.
- Open Access
- 1 January 2022
- Published by FapUNIFESP (SciELO) in Genetics and Molecular Biology
- Vol. 45 (3) , e20210419
Alterations of actin cytoskeleton and arterial protein level in patients with obstructive jaundice
Vascular hypo-responsiveness to vasopressors in patients with obstructive jaundice (OJ) is a common anesthetic event, which leads to perioperative complications and increased mortality. The cause of this clinical issue remains unclear. In this study, we estimated the actin cytoskeleton and arterial protein level in the artery of OJ patients by proteomic analysis. Ten patients with OJ due to bile duct diseases or pancreatic head carcinoma were enrolled, while another ten non-jaundice patients with chronic cholecystitis or liver hemangioma as the control group. Vascular reactivity to noradrenaline was measured before anesthesia on the day of surgery. Artery samples in adjacent tissues of removed tumor were collected and evaluated by 2-dimensional electrophoresis. Proteins with differential expression were detected by MALDI-TOF mass spectrometry with immunoblot confirmation. The results confirmed the phenomenon of vascular hypo-reactivity in OJ patients as suppressed aortic response to noradrenaline were existed in these patients. We also found that actin cytoskeleton and several actin-binding proteins were up- or down-regulated in the artery of OJ patients. These proteins changed in OJ patents might be the basic mechanism of vascular hypo-reactivity, further studies to uncover the role of these proteins in OJ is critical for clinical treatment of these patients.
- 1 January 2022
- Published by FapUNIFESP (SciELO) in Genetics and Molecular Biology
- Vol. 45 (3) , e20210419
Open AccessAlterations of actin cytoskeleton and arterial protein level in patients with obstructive jaundice
Vascular hypo-responsiveness to vasopressors in patients with obstructive jaundice (OJ) is a common anesthetic event, which leads to perioperative complications and increased mortality. The cause of this clinical issue remains unclear. In this study, we estimated the actin cytoskeleton and arterial protein level in the artery of OJ patients by proteomic analysis. Ten patients with OJ due to bile duct diseases or pancreatic head carcinoma were enrolled, while another ten non-jaundice patients with chronic cholecystitis or liver hemangioma as the control group. Vascular reactivity to noradrenaline was measured before anesthesia on the day of surgery. Artery samples in adjacent tissues of removed tumor were collected and evaluated by 2-dimensional electrophoresis. Proteins with differential expression were detected by MALDI-TOF mass spectrometry with immunoblot confirmation. The results confirmed the phenomenon of vascular hypo-reactivity in OJ patients as suppressed aortic response to noradrenaline were existed in these patients. We also found that actin cytoskeleton and several actin-binding proteins were up- or down-regulated in the artery of OJ patients. These proteins changed in OJ patents might be the basic mechanism of vascular hypo-reactivity, further studies to uncover the role of these proteins in OJ is critical for clinical treatment of these patients.
- 18 August 2021
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 28 (13) , 8174-8185
Preoperative Estimated Risk of Microvascular Invasion is Associated with Prognostic Differences Following Liver Resection Versus Radiofrequency Ablation for Early Hepatitis B Virus-Related Hepatocellular Carcinoma
The aim of this study was to examine prognostic differences between liver resection (LR) and percutaneous radiofrequency ablation (PRFA) for hepatocellular
- 18 August 2021
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 28 (13) , 8174-8185
Preoperative Estimated Risk of Microvascular Invasion is Associated with Prognostic Differences Following Liver Resection Versus Radiofrequency Ablation for Early Hepatitis B Virus-Related Hepatocellular Carcinoma
The aim of this study was to examine prognostic differences between liver resection (LR) and percutaneous radiofrequency ablation (PRFA) for hepatocellular
- 1 July 2013
- Vol. 126 (13) , 2573-6
Imaging features and appropriate treatment strategy of a rare biliary tract neoplasm.
- 1 July 2013
- Vol. 126 (13) , 2573-6
Imaging features and appropriate treatment strategy of a rare biliary tract neoplasm.